GENE ONLINE|News &
Opinion
Blog

Deals
Astellas Secures Licensing Agreement with 4D Molecular Therapeutics for Gene Therapy Vector Technology
2023-07-12
Evotec SE has secured a contract valued at up to $74M from the U.S. Department of Defense to Combat Orthopoxviruses
2023-07-12
Nanobiotix Partners with Janssen to Co-develop and Commercialize Groundbreaking Radioenhancer, NBTXR3
2023-07-10
F-star Announces Collaboration with Takeda to Develop Next Generation Immunotherapeutics
2023-07-09
Merger Announced Between Immunome and Morphimmune
2023-07-05
Moonlake Announces $250 Million Public Offering
2023-06-29
The Gates Foundation and Wellcome Join Forces to Fund Late-Stage Tuberculosis Vaccine
2023-06-29
Vertex and Lonza Collaborate to Revolutionize Type 1 Diabetes Treatment
2023-06-29
Coherus Acquiring Surface Oncology in $65M Stock Deal
2023-06-27
Novartis Plans to Acquire Chinook Therapeutics in a Potential $3.5B Deal, Revolutionizing IgAN Treatment Landscape
2023-06-14
Sun Pharma Acquired Taro in an All-cash-deal
2023-06-09
Rona Therapeutics, Keymed Biosciences Team Up To Develop siRNA Drugs For Kidney Disease
2023-05-25
Angelini Pledges Over $500 Million in Biobucks for JCR’s Epilepsy Therapy Tech
2023-05-11
Ginkgo and Boehringer Join Forces in a $406 Million Partnership to Uncover New Therapeutic Molecules
2023-05-11
Boehringer, Kinoxis Ink $181 Million Pact To Target Oxytocin Receptors
2023-05-08
1 4 5 6 7 8 47
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top